Directory
>
Jim Frates
Jim Frates
analyst | Amylyx Pharmaceuticals
Massachusetts, Cambridge, United States
Jim Frates
Summary
Jim Frates is an accomplished Chief Financial Officer with extensive experience in the biotechnology and investment banking sectors. He currently leads the financial strategies at Amylyx Pharmaceuticals, a company focused on innovative treatments for neurological diseases. Prior to this role, Jim served as CFO at Alkermes, where he honed his expertise in financial management within the biotech industry. His career also includes a significant tenure as Vice President at Robertson Stephens, where he specialized in biotechnology investment banking. Jim is a graduate of Harvard University, holding a Bachelor's degree in Political Science, and furthered his education at Harvard Business School. His unique blend of skills in finance and biotechnology positions him as a key player in the industry. Outside of work, Jim is passionate about leveraging financial strategies to drive innovation in healthcare.
Jim Frates
Work Experience
Chief Financial Officer at
Amylyx Pharmaceuticals
January 2021 - Present
Jim Frates
Education
Harvard University, Bachelor's degree, Political Science and Government
St. Paul's School
Harvard Business School
January 1994 - January 1996
Frequently Asked Questions about Jim Frates
What is Jim Frates email address?
Jim Frates's primary email address is **********@amylyx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jim Frates work for?
Jim Frates is a analyst at Amylyx Pharmaceuticals.
Where Jim Frates graduated from?
Jim Frates holds a degree in null from Harvard University.
How can I directly contact Jim Frates?
To contact Jim Frates directly, you can use the email address **********@amylyx.com. Complete contact information is available upon registration with Muraena.
Who is Jim Frates?
Jim Frates is an accomplished Chief Financial Officer with extensive experience in the biotechnology and investment banking sectors. He currently leads the financial strategies at Amylyx Pharmaceuticals, a company focused on innovative treatments for neurological diseases. Prior to this role, Jim served as CFO at Alkermes, where he honed his expertise in financial management within the biotech industry. His career also includes a significant tenure as Vice President at Robertson Stephens, where he specialized in biotechnology investment banking. Jim is a graduate of Harvard University, holding a Bachelor's degree in Political Science, and furthered his education at Harvard Business School. His unique blend of skills in finance and biotechnology positions him as a key player in the industry. Outside of work, Jim is passionate about leveraging financial strategies to drive innovation in healthcare.
Jim`s contact details
**********@amylyx.com
**********@alkermes.com
Colleagues
Undergraduate Neuroscience Researcher
Senior Director
Engineering Researcher